Ted R Mikuls1, Amy S Mudano, LeaVonne Pulley, Kenneth G Saag. 1. Department of Medicine, Section of Rheumatology and Immunology, University of Nebraska Medical Center and the Omaha VA Medical Center, Omaha, Nebraska, USA.
Abstract
BACKGROUND: The role of race/ethnicity in the receipt of arthritis-specific health care has not been well defined. OBJECTIVE: To examine the association of race/ethnicity with the utilization of arthritis health care among community-dwelling older adults. RESEARCH DESIGN: We used a computer-assisted telephone interview. SUBJECTS: A population-based random sample was drawn from 6 preselected Alabama counties. Eligible respondents had self-reported arthritis and were over 50 years of age; 1424 people responded to the survey. MEASURES: Logistic regression was used to examine the association of race/ethnicity with the use of conventional (including use of a rheumatologist, primary care physician, and prescription arthritis medicines) and complementary and alternative medicines (CAM), including the use of chiropractic care, glucosamine and/or chondroitin, and herbals. RESULTS: Reflecting stratified sampling, respondents were white (n=852, 60%) or black (n=528, 37%), female (72%), and had a mean age of 65 years. After multivariable adjustment, race/ethnicity was not a significant determinant of receiving rheumatology care or prescription arthritis medicines. However, whites were more likely than blacks to have seen a primary care physician for arthritis care (adjusted odds ratio [OR], 1.49; 95% confidence interval [CI], 1.12-1.98) or to have used CAM (OR, 1.47; 95% CI, 1.13-1.91) and twice as likely to have used glucosamine and/or chondroitin (OR, 1.99; 95% CI, 1.30-3.05). CONCLUSION: In this population of community-dwelling older adults, white race was significantly associated with CAM use and visits to primary care physicians for arthritis care. In contrast, the use of specialists and prescription arthritis medications was better explained by factors other than race/ethnicity, which included female gender, urban residence, higher educational level, and other arthritis-specific variables.
BACKGROUND: The role of race/ethnicity in the receipt of arthritis-specific health care has not been well defined. OBJECTIVE: To examine the association of race/ethnicity with the utilization of arthritis health care among community-dwelling older adults. RESEARCH DESIGN: We used a computer-assisted telephone interview. SUBJECTS: A population-based random sample was drawn from 6 preselected Alabama counties. Eligible respondents had self-reported arthritis and were over 50 years of age; 1424 people responded to the survey. MEASURES: Logistic regression was used to examine the association of race/ethnicity with the use of conventional (including use of a rheumatologist, primary care physician, and prescription arthritis medicines) and complementary and alternative medicines (CAM), including the use of chiropractic care, glucosamine and/or chondroitin, and herbals. RESULTS: Reflecting stratified sampling, respondents were white (n=852, 60%) or black (n=528, 37%), female (72%), and had a mean age of 65 years. After multivariable adjustment, race/ethnicity was not a significant determinant of receiving rheumatology care or prescription arthritis medicines. However, whites were more likely than blacks to have seen a primary care physician for arthritis care (adjusted odds ratio [OR], 1.49; 95% confidence interval [CI], 1.12-1.98) or to have used CAM (OR, 1.47; 95% CI, 1.13-1.91) and twice as likely to have used glucosamine and/or chondroitin (OR, 1.99; 95% CI, 1.30-3.05). CONCLUSION: In this population of community-dwelling older adults, white race was significantly associated with CAM use and visits to primary care physicians for arthritis care. In contrast, the use of specialists and prescription arthritis medications was better explained by factors other than race/ethnicity, which included female gender, urban residence, higher educational level, and other arthritis-specific variables.
Authors: Michele Montgomery; Sujuan Huang; Cheryl L Cox; Wendy M Leisenring; Kevin C Oeffinger; Melissa M Hudson; Jill Ginsberg; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness Journal: J Cancer Surviv Date: 2010-10-05 Impact factor: 4.442
Authors: E R Vina; L R M Hausmann; D S Obrosky; A Youk; S A Ibrahim; D K Weiner; R M Gallagher; C K Kwoh Journal: Osteoarthritis Cartilage Date: 2019-02-01 Impact factor: 6.576
Authors: Ashutosh Tamhane; Gerald McGwin; David T Redden; Laura B Hughes; Elizabeth E Brown; Andrew O Westfall; Doyt L Conn; Beth L Jonas; Edwin A Smith; Richard D Brasington; Larry W Moreland; S Louis Bridges; Leigh F Callahan Journal: Arthritis Care Res (Hoboken) Date: 2014-02 Impact factor: 4.794
Authors: Ernest R Vina; Michael J Hannon; Hana S Masood; Leslie R M Hausmann; Said A Ibrahim; Jazmin Dagnino; Andrea Arellano; C Kent Kwoh Journal: Am J Med Date: 2019-12-17 Impact factor: 4.965
Authors: Shibing Yang; Rachel Jawahar; Timothy E McAlindon; Charles B Eaton; Kate L Lapane Journal: BMC Complement Altern Med Date: 2012-07-06 Impact factor: 3.659